Theralase Technologies Inc.
TLT.V
TSX
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
9/17/2025
-
MarketBeat
10/31/2025
-
ETF Channel
10/30/2025
-
Tickeron - Technical Analysis
10/30/2025
-
Tickeron - Technical Analysis
10/24/2025
-
Tickeron - Technical Analysis
10/23/2025
-
Fool.com Headlines
10/23/2025
-
Nasdaq News: ETFs
10/23/2025
-
ETF Channel
10/22/2025
-
TheStreet.com
10/21/2025
-
Tickeron - Technical Analysis
10/18/2025
-
Tickeron - Technical Analysis
10/17/2025
-
Tickeron - Technical Analysis
10/16/2025
-
Tickeron - Technical Analysis
10/15/2025
-
Nasdaq News: ETFs
10/15/2025
-
ETF Channel
10/15/2025
-
Tickeron - Technical Analysis
10/14/2025
-
Fool.com Headlines
10/14/2025
-
24/7 Wall St.
10/14/2025
-
Tickeron - Technical Analysis
10/11/2025
-
Tickeron - Technical Analysis
10/11/2025
-
Tickeron - Technical Analysis
10/7/2025
-
Nasdaq News: ETFs
10/7/2025
-
ETF Channel
10/7/2025
-
Tickeron - Technical Analysis
8/5/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 26, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 24 and 28 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
416 699 5273
Address
41 Hollinger Road
Toronto, ON M4B 3G4
Toronto, ON M4B 3G4
Country
Year Founded
--
Business Description
Sector
Industry
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated...
more